# FDA Inspection 748465 - Guangxi Yulin Pharmaceutical Group Co. Ltd. - September 22, 2011

Source: https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/3b262c58-6d65-429e-affe-36929fbbb2e4
Source feed: FDA_Inspections

> FDA Inspection 748465 for Guangxi Yulin Pharmaceutical Group Co. Ltd. on September 22, 2011. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 748465
- Company Name: Guangxi Yulin Pharmaceutical Group Co. Ltd.
- Inspection Date: 2011-09-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1268116 - 2025-03-21](https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/82a89afe-506e-4e84-9dd2-02a225853a04)
- [FDA Inspection 992915 - 2016-09-29](https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/3234756c-c4c4-4f85-9e17-82bfde214835)
- [FDA Inspection 992915 - 2016-09-29](https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/53547aca-4a56-4e32-a161-c8403b574891)

Company: https://www.keypedia.com/companies/guangxi-yulin-pharmaceutical-group-co-ltd/3815cb2a-39f8-4338-9e21-e6dcd7f7a015

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c